Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)

China flag China · Delayed Price · Currency is CNY
9.58
-0.06 (-0.62%)
At close: Mar 9, 2026
11.01%
Market Cap 15.97B
Revenue (ttm) 2.58B
Net Income (ttm) 668.71M
Shares Out 1.67B
EPS (ttm) 0.40
PE Ratio 23.85
Forward PE n/a
Dividend 0.30 (3.11%)
Ex-Dividend Date n/a
Volume 13,877,580
Average Volume 15,507,742
Open 9.54
Previous Close 9.64
Day's Range 9.49 - 9.63
52-Week Range 7.38 - 13.06
Beta 0.56
RSI 41.31
Earnings Date Mar 31, 2026

About SHE:300009

Anhui Anke Biotechnology (Group) Co., Ltd. engages in the biopharmaceutical industry in China and internationally. The company offers human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life det... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 2,647
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300009
Full Company Profile

Financial Performance

In 2024, SHE:300009's revenue was 2.54 billion, a decrease of -11.51% compared to the previous year's 2.87 billion. Earnings were 706.95 million, a decrease of -16.56%.

Financial Statements

News

There is no news available yet.